[Intradermal needling combined with heat-sensitive moxibustion for moderate to severe cancer pain].

干刺 艾灸 医学 针灸科 皮内注射 皮肤病科 替代医学 病理 免疫学
出处
期刊:Chinese acupuncture & moxibustion 卷期号:41 (7): 725-9
标识
DOI:10.13703/j.0255-2930.20200615-k0002
摘要

To observe the effect of intradermal needling combined with heat-sensitive moxibustion for moderate to severe cancer pain.A total of 60 patients with moderate to severe cancer pain were randomly divided into an observation group and a control group,30 cases in each one. In the control group,opioids were taken to relief pain according to the three-step analgesic method of World Health Organization. On the base of the treatment as the control group, intradermal needling combined with heat-sensitive moxibustion were applied at Neiguan (PC 6), Hegu (LI 4), Zusanli (ST 36), Taichong (LR 3), etc. in the observation group, 14 days of treatment were required. The equivalent morphine consumption at the first day and whole course, the scores of cancer quality of life questionnaire-C30 (QLQ-C30) and Hamilton anxiety scale before and after treatment, and the adverse reaction rate were compared in the two groups. The total analgesic effective rate was evaluated.The total analgesic effective rate was 93.3% (28/30) in the observation group, higher than 73.3% (22/30) in the control group (P<0.05). The total equivalent morphine consumption in the observation group was less than the control group (P<0.05). After treatment, the QLQ-C30 scores were increased (P<0.001) and the HAMA scores were decreased (P<0.001) in the both groups, and those in the observation group were superior to the control group (P<0.001). The adverse reaction rates of fatigue, dizziness, nausea and vomiting, constipation in the observation group were lower than the control group (P<0.05).Intradermal needling combined with heat-sensitive moxibustion can reduce the dose of opioids, improve the quality of life, relief the anxiety in patients with moderate to severe cancer pain, and reduce the incidence of common adverse reaction of opioids.目的:观察揿针联合热敏灸治疗中重度癌性疼痛的临床效应。方法:将60例中重度癌性疼痛患者随机分为观察组和对照组,每组30例。对照组根据世界卫生组织“三阶梯药物止痛法”选用阿片类药物进行止痛治疗;观察组在对照组治疗基础上,穴取内关、合谷、足三里、太冲等,予揿针联合热敏灸干预,疗程为14 d。比较两组患者首日及全程等效吗啡消耗量,治疗前后癌症患者生活质量测定量表(QLQ-C30)评分、汉密尔顿焦虑量表(HAMA)评分及不良反应发生率,并比较两组患者镇痛总有效率。结果:观察组镇痛总有效率为93.3%(28/30),高于对照组的73.3%(22/30,P<0.05)。观察组全程等效吗啡消耗量少于对照组(P<0.05)。治疗后,两组QLQ-C30评分增加(P<0.001),HAMA评分下降(P<0.001),且观察组评分均优于对照组(P<0.001)。观察组患者乏力、眩晕、恶心呕吐及便秘的发生率低于对照组(P<0.05)。结论:揿针联合热敏灸治疗可减少中重度癌性疼痛患者阿片类药物使用量,改善生活质量,减轻焦虑状态,且可减少阿片类药物常见不良反应的发生率。.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
善学以致用应助周周采纳,获得30
刚刚
刚刚
思源应助科研通管家采纳,获得100
2秒前
ccyyqq应助科研通管家采纳,获得10
2秒前
2秒前
巴卫应助科研通管家采纳,获得10
2秒前
orixero应助科研通管家采纳,获得10
2秒前
上官若男应助科研通管家采纳,获得10
2秒前
Orange应助科研通管家采纳,获得10
2秒前
无花果应助科研通管家采纳,获得10
2秒前
2秒前
CodeCraft应助科研通管家采纳,获得10
2秒前
3秒前
Twonej应助科研通管家采纳,获得10
3秒前
3秒前
大模型应助科研通管家采纳,获得10
3秒前
3秒前
bkagyin应助科研通管家采纳,获得10
3秒前
3秒前
4秒前
Peter王完成签到,获得积分10
4秒前
Shen发布了新的文献求助10
4秒前
陈词丶发布了新的文献求助10
5秒前
kililolo完成签到,获得积分10
5秒前
无花果应助fiona采纳,获得10
5秒前
NearYP完成签到,获得积分10
5秒前
Akim应助季生采纳,获得10
5秒前
6秒前
汉堡包应助任性的元冬采纳,获得10
6秒前
7秒前
wanci应助超级的楼房采纳,获得10
7秒前
hzk发布了新的文献求助10
8秒前
8秒前
慕青应助王歪歪采纳,获得10
9秒前
Xue0129发布了新的文献求助10
10秒前
10秒前
Alicer完成签到,获得积分20
11秒前
12秒前
12秒前
ccc完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Real Analysis: Theory of Measure and Integration (3rd Edition) Epub版 1200
AnnualResearch andConsultation Report of Panorama survey and Investment strategy onChinaIndustry 1000
卤化钙钛矿人工突触的研究 1000
Engineering for calcareous sediments : proceedings of the International Conference on Calcareous Sediments, Perth 15-18 March 1988 / edited by R.J. Jewell, D.C. Andrews 1000
Continuing Syntax 1000
Production of doubled haploid plants ofCucurbitaceaefamily crops through unpollinated ovule culture in vitro 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6266878
求助须知:如何正确求助?哪些是违规求助? 8088191
关于积分的说明 16906247
捐赠科研通 5337045
什么是DOI,文献DOI怎么找? 2840365
邀请新用户注册赠送积分活动 1817743
关于科研通互助平台的介绍 1671083